Stocktoria

Veradermics, Inc MANE

NYSE · stock · Pharmaceutical Preparations · website · IPO 2026-02-04

Veradermics, Inc statistics & valuation

Market cap$5.3B
Return on capital-50.4%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Gross margin (%)
20242025
Operating margin (%)
20242025
Return on equity (%)
20242025
Shares outstanding
736933 749760 20242025
Net debt ($)
20242025
Share buybacks ($)
20242025
Return on assets (%)
-47.70% -45.90% 20242025
Free cash flow margin (%)
20242025
Debt / equity (×)
20242025
EPS ($)
-$37.05 -$111.91 20242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024
Return on assets-45.9%-47.7%
Return on equity57.8%54.6%
Current ratio16.6611.77

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.